Combined supplementation of short-chain fatty acids reduces hyperphosphorylation of Tau at T181,T231 and S396 sites and improves cognitive impairment in a chemically induced AD mouse model via regulation of HDAC and Keap1
Authors:
- 12 August 2025
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 189, 106034
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- A Family of Cyclic Lipopeptides Found in Human Isolates of Bacillus Ameliorates Acute Colitis via Direct Agonism of Toll-Like Receptor 2 in a Murine Model of Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2024
- The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer’s DiseaseMolecular Neurobiology, 2024
- Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous HormonesNeurochemical Research, 2022
- Global estimates on the number of persons across the Alzheimer's disease continuumAlzheimer's & Dementia, 2022
- Systemic inflammation elicits distinct brain immune signaling dynamics in female and male mice with AD pathologyAlzheimer's & Dementia, 2021
- The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative diseaseAgeing Research Reviews, 2021
- Stable isotope labeling combined with liquid chromatography-tandem mass spectrometry for comprehensive analysis of short-chain fatty acidsAnalytica Chimica Acta, 2019
- Sodium Butyrate Prevents Memory Impairment by Re-establishing BDNF and GDNF Expression in Experimental Pneumococcal MeningitisMolecular Neurobiology, 2014
- Modulation of Inflammatory Cytokines and Mitogen-activated Protein Kinases by Acetate in Primary AstrocytesJournal of Neuroimmune Pharmacology, 2012
- Sodium butyrate induces aberrant tau phosphorylation and programmed cell death in human neuroblastoma cellsBrain Research, 1995